awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42510237-53C274FB-5696-41A5-BDAC-BB9A23252128
Q42510237-53C274FB-5696-41A5-BDAC-BB9A23252128
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42510237-53C274FB-5696-41A5-BDAC-BB9A23252128
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan.
P2860
Q42510237-53C274FB-5696-41A5-BDAC-BB9A23252128
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42510237-53C274FB-5696-41A5-BDAC-BB9A23252128
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5feb03c26cec6c45e2078b9f2b4b155e686554b
P2860
Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.